MEDICAL PROPERTIES TRUST INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations $903.8m ($556.1m) ($2.4b) ($275.9m)
Net Income (Loss) Attributable to Parent $225.0m $289.8m $1.0b $374.7m $431.4m $656.0m $902.6m ($556.5m) ($2.4b) ($277.0m)
Gain (Loss) on Disposition of Real Estate, Discontinued Operations ($2.8m) $52.5m $5.5m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $225.9m $291.2m $1.0b $376.4m $432.3m $656.9m $903.8m ($556.1m) ($2.4b) ($275.9m)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $225.9m $291.2m
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($1k)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent ($1k)
Net Income (Loss) Attributable to Noncontrolling Interest $889k $1.4m $1.8m $1.7m $822k $919k $1.2m $384k $2.0m $1.1m
Depreciation, Depletion and Amortization $97.6m $132.0m $141.5m $156.6m $276.0m $333.8m $345.6m $616.1m $453.7m $272.8m
Amortization of Debt Issuance Costs and Discounts $7.6m $6.5m $7.4m $8.9m $13.1m $16.9m $17.0m $15.8m $17.3m $26.3m
Depreciation Amortization Depletion $345.6m $616.1m $453.7m $272.8m
Deferred Income Tax Expense (Benefit) ($8.7m) ($340k) ($2.2m) ($4.2m) $20.9m $53.4m $29.3m ($162.7m) $13.0m $10.6m
Deferred Income Tax $10.7m ($167.3m) $5.1m ($11.2m)
Deferred Tax $10.7m ($167.3m) $5.1m ($11.2m)
Share-based Payment Arrangement, Noncash Expense $7.9m $9.9m $16.5m $32.2m $47.2m $52.1m $49.4m $33.2m $33.0m $25.7m
Payment, Tax Withholding, Share-based Payment Arrangement $29.9m $8.1m $3.8m $2.5m
Share-based Payment Arrangement, Expense $7.9m $9.9m
Asset Impairment Charge $268.4m $376.9m $2.2b $193.9m
Income (Loss) from Equity Method Investments $16.1m $20.4m $28.5m $40.8m $14.0m ($366.6m) $97.9m
Gain (Loss) on Disposition of Other Assets $61.2m
Income Tax Expense (Benefit) ($6.8m) $2.7m $927k ($2.6m) $31.1m $73.9m $55.9m ($130.7m) $44.1m $38.6m
Other Nonoperating Income (Expense) ($502k) $374k $10.1m ($345k) ($6.8m) $6.3m $15.3m $7.6m ($615.6m) ($172.6m)
Earnings (Loss)es From Equity Investments ($40.9m) $0 $0
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Other Operating Assets $18.4m $4.5m $18.1m $5.0m ($18.3m) $4.4m $4.0m ($13.8m) $36.1m ($15.0m)
Payments of Financing Costs $15.5m $32.8m $30.2m
General and Administrative Expense $48.9m $58.6m $80.1m $96.4m $131.7m $145.6m $160.5m $145.6m $133.8m $130.4m
Nonoperating Income (Expense) ($115.7m) ($194.3m) $681.5m $30.1m ($36.4m) $59.6m $315.1m ($356.9m) ($2.3b) ($266.7m)
Financing Receivable, Credit Loss, Expense (Reversal) $41.7m $99.0m $10.2m $1.2b $168.2m
Beginning Cash Position $461.9m $241.5m $256.0m $335.2m
Cash Flow From Continuing Financing Activities ($1.3b) ($1.0b) ($1.5b) $228.1m
Cash Flow From Continuing Investing Activities $396.1m $517.6m $1.3b ($264.7m)
Change In Other Current Assets ($4.0m) $13.8m ($36.1m) $15.0m
Change In Other Working Capital $43k $7.6m ($5.8m) ($9.6m)
Change In Payables And Accrued Expense $33.6m ($4.6m) $23.5m $21.7m
Change In Receivables ($116.4m) ($141.7m) $2.8m $7.1m
Change In Working Capital ($86.8m) ($125.0m) ($15.6m) $34.2m
Changes In Cash ($207.5m) $3.0m $84.4m $194.1m
End Cash Position $241.5m $256.0m $335.2m $544.0m
Financing Cash Flow ($1.3b) ($1.0b) ($1.5b) $228.1m
Free Cash Flow $739.0m $505.8m $245.5m $230.8m
Gain Loss On Investment Securities ($536.8m) $1.8m ($478.7m) ($5.5m)
Investing Cash Flow $396.1m $517.6m $1.3b ($264.7m)
Issuance Of Capital Stock $1.1b $0 $0
Net Business Purchase And Sale ($1.3b) ($222.8m) ($94.0m) ($142.1m)
Operating Gains Losses ($536.8m) $1.8m ($478.7m) ($5.5m)
Other Non Cash Items ($215.3m) $326.1m $420.0m ($3.2m)
Proceeds From Stock Option Exercised ($29.9m) ($8.1m) ($3.8m) ($2.5m)
Purchase Of Business ($1.3b) ($235.2m) ($105.6m) ($142.1m)
Repurchase Of Capital Stock ($17.9m) $0 $0 ($23.4m)
Sale Of Business $14.3m $12.4m $11.7m $0
Stock Based Compensation $49.4m $33.2m $33.0m $25.7m
Net Cash Provided by (Used in) Operating Activities $264.7m $363.1m $449.1m $494.1m $617.6m $811.7m $739.0m $505.8m $245.5m $230.8m
Cash flows from investing activities:
Net Investment Properties Purchase And Sale $2.1b $783.1m $1.8b $40.5m
Net Investment Purchase And Sale ($207.4m) ($294.2m) ($156.1m) ($73.8m)
Purchase Of Investment ($207.4m) ($294.2m) ($156.1m) ($73.8m)
Purchase Of Investment Properties ($109.2m) ($114.4m) ($79.8m) ($80.0m)
Gains (Losses) on Sales of Investment Real Estate $61.2m $7.4m $719.4m $41.6m ($2.8m) $52.5m $536.8m ($1.8m) $478.7m $5.5m
Sale Of Investment Properties $2.2b $897.5m $1.9b $120.5m
Net Other Investing Changes ($154.2m) $251.4m ($205.9m) ($89.4m)
Net Cash Provided by (Used in) Investing Activities ($926.5m) ($2.4b) $564.2m ($4.9b) ($2.9b) ($3.9b) $396.1m $517.6m $1.3b ($264.7m)
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt $1.0b $2.4b $759.7m $3.0b $2.2b $3.4b $128.5m $804.2m $2.5b
Issuance Of Debt $332.1m $567.9m $804.2m $2.8b
Long Term Debt Issuance $332.1m $567.9m $804.2m $2.8b
Net Issuance Payments Of Debt ($537.5m) ($420.3m) $102.4m $501.8m
Net Long Term Debt Issuance ($537.5m) ($420.3m) $102.4m $501.8m
Net Short Term Debt Issuance $560.0m $203.6m $567.9m
Repayments of Long-term Debt $575.3m $1.0b $800.0m $1.4b $869.6m $988.2m $701.8m $2.3b
Long Term Debt Payments ($869.6m) ($988.2m) ($701.8m) ($2.3b)
Repayment Of Debt ($869.6m) ($988.2m) ($701.8m) ($2.3b)
Proceeds from Issuance of Common Stock $1.2b $547.8m $94.2m $2.5b $411.1m $1.1b
Common Stock Issuance $1.1b $0 $0
Net Common Stock Issuance ($17.9m) $0 $0 ($23.4m)
Payments for Repurchase of Common Stock $17.9m $23.4m
Common Stock Payments ($17.9m) $0 $0 ($23.4m)
Dividends Payable $74.5m $89.4m $95.4m $138.2m $147.7m $176.5m $176.6m $92.8m $48.2m $55.4m
Cash Dividends Paid ($698.5m) ($615.4m) ($321.1m) ($193.3m)
Common Stock Dividend Paid ($698.5m) ($615.4m) ($321.1m) ($193.3m)
Proceeds from (Payments for) Other Financing Activities ($16.5m) ($13.0m) ($3.6m) ($19.9m) ($42.3m) ($54.5m) ($53.6m) $13.3m ($127.8m) ($50.6m)
Net Other Financing Charges ($58.6m) $23.4m ($1.3b) ($54.5m)
Net Cash Provided by (Used in) Financing Activities $552.6m $2.1b ($345.9m) $5.0b $1.4b $2.9b ($1.3b) ($1.0b) ($1.5b) $228.1m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($17.2m) ($6.5m) $16.4m $4.7m ($12.9m) $11.4m ($5.2m) $14.7m
Effect Of Exchange Rate Changes ($12.9m) $11.4m ($5.2m) $14.7m
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported ($207.5m) $3.0m $84.4m $194.1m
Interest Paid CFO ($23.9m) ($116.4m) ($141.7m)
Income Taxes Paid, Net $20.5m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.